Healthcare technology startup Zoplar has announced the successful closure of its Series A funding round, securing $3.4 million to accelerate its mission of streamlining medical supply procurement across India. The funding round was led by Blume Ventures, with participation from BEENEXT, Saison Capital, Atrium Angels, Finfirst, and LogX Ventures.

Founded in 2022 by Amit Sah and Umesh Sharma, Zoplar aims to solve one of the healthcare sector’s most persistent challenges: fragmented and inefficient procurement systems. By leveraging data-driven technology and a unified digital platform, the company has created a streamlined, end-to-end procurement experience tailored to the unique needs of hospitals, clinics, and diagnostic centers.

With the newly raised capital, Zoplar plans to scale its operations, enhance its technology infrastructure, and deepen its penetration into the Indian healthcare market. A significant portion of the funds will be invested in expanding its supplier base and logistics capabilities, enabling faster fulfillment and a broader catalog of verified medical products. The company also intends to strengthen its workforce across tech, operations, and customer success functions.

Speaking on the funding milestone, co-founders Amit Sah and Umesh Sharma expressed excitement about the future: “This investment is not just financial backing—it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies. It motivates us to scale our impact, enhance our offerings, and continue empowering healthcare providers to deliver uninterrupted care.”

Zoplar’s digital procurement platform acts as a centralized marketplace where healthcare institutions can discover, compare, and order a wide range of medical supplies—ranging from surgical tools to PPE and lab equipment—all from verified vendors. The platform uses intelligent algorithms to recommend optimal procurement strategies based on inventory levels, pricing trends, and vendor reliability. This reduces manual intervention and minimizes delays or stock-outs, which are critical concerns in a sector where time-sensitive medical supplies are often lifesaving.

The healthcare procurement market in India is ripe for disruption. Hospitals typically rely on traditional, paper-based processes and fragmented vendor relationships, leading to inefficiencies, inflated costs, and inconsistencies in supply quality. Zoplar aims to change this by offering an intelligent, scalable alternative that ensures quality assurance and timely deliveries. By integrating procurement, inventory, and analytics in one ecosystem, the platform brings much-needed digitization to a largely offline process.

Investors in the Series A round highlighted the importance of Zoplar’s solution in a post-pandemic world, where the demand for streamlined medical logistics has become more pronounced. Sajith Pai, VC at Blume Ventures, stated, “We invested in Zoplar because we believe in their vision and the potential impact they can have on the healthcare landscape in India.”

Since its inception, Zoplar has partnered with over 100 healthcare institutions, including leading hospitals and diagnostic labs, serving thousands of patients daily through improved access to medical supplies. The startup has also earned recognition for its user-centric platform design and commitment to compliance and data security.

Looking ahead, Zoplar aims to onboard thousands of hospitals and health centers across tier-2 and tier-3 cities, where access to reliable medical procurement options remains limited. The startup is also exploring AI-driven analytics features to help hospitals predict procurement needs and manage budgets more efficiently.

As India continues to invest in modernizing its healthcare systems, companies like Zoplar are poised to play a pivotal role. With its latest funding round, Zoplar not only reinforces its commitment to innovation but also solidifies its place as a key enabler of healthcare accessibility and efficiency.